Sort
53,477 grants matching “addiction”
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects
$585,731Lauren M Jansson · Johns Hopkins University · R01 · FY2019 · DA
Genetic basis of nicotine withdrawal in a reduced complexity cross
$585,690Mohamad Imad Damaj · Virginia Commonwealth University · U01 · FY2020 · DA
Bupropion for ADHD in Adolescents with Substance Use Disorders
$585,641Paula Riggs · University Of Colorado Denver · R01 · FY2012 · DA
Enhancing Relapse Prevention with rTMS: Dose-Response Parameters for Smoking Cessation
$585,641Christine Elizabeth Sheffer · Roswell Park Cancer Institute Corp · R01 · FY2018 · CA
Nucleus accumbens processing of reward-predictive cues
$585,624Saleem M Nicola · Albert Einstein College Of Medicine · R01 · FY2025 · DA
Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy
$585,613Susan G Dorsey · University Of Maryland Baltimore · R01 · FY2017 · NR
NEUROCOGNITION, GENETICS, AND ADOLESCENT SUBSTANCE ABUSE
$585,601Andrey P. Anokhin · Washington University · R01 · FY2012 · DA
Impact of prenatal opioid exposure on corticostriatal circuits that modulate alcohol-related behaviors
$585,574Brady Atwood · Indiana University Indianapolis · R01 · FY2023 · AA
SAFETY OF A NICOTINE REDUCTION STRATEGY
$585,563University Of California San Francisco · R01 · FY2002 · CA
Using a Genetic Approach to Understand Factors Influencing Resistance to Substance Use
$585,515Elizabeth Chin Prom-Wormley · Virginia Commonwealth University · R01 · FY2022 · DA
Intensive Motivational Interviewing for Methamphetamine Dependence
$585,509Douglas L Polcin · Public Health Institute · R01 · FY2010 · DA
Extended Treatment for Smoking Cessation
$585,473Sean P. David · Stanford University · R01 · FY2011 · DA
Implementation, Outcomes, and Cost of a Novel Medicaid Policy to Reduce Opioids for Back Pain
$585,315Esther K Choo · Oregon Health & Science University · R01 · FY2021 · DA
Inhibitory Cell Types and Circuits in the Lateral Hypothalamus
$585,300Alexander Choi Jackson · University Of Connecticut Storrs · R01 · FY2022 · MH
The lipid hydrolase NAAA as a target for non-addictive analgesic medications
$585,262Daniele Piomelli · University Of California-Irvine · R01 · FY2023 · DA
Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacology
$585,248Jonathan A Javitch · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2024 · NS
Impact of comorbidity of HIV infection and substance use disorder on brain aging and cognitive impairment
$585,200Yihong Yang · National Institute On Drug Abuse · ZIA · FY2024 · DA
Alcohol Stimulation and Sedation in Binge Drinkers - Renewal 01
$585,173Andrea C King · University Of Chicago · R01 · FY2023 · AA
Project 1
$585,149Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2013 · CA
Understanding the Impact of Vaping Prevention Ads on Adolescents and Young Adults
$585,134Seth Michael Noar · Univ Of North Carolina Chapel Hill · U54 · FY2025 · DA
1 of 2: Real-time fMRI Pattern Training for Treatment of Craving and Addiction
$585,132Anna Rose Childress · University Of Pennsylvania · R21 · FY2009 · DA
Succinylation and Malonylation as Novel Protein Modifications in Cancer
$585,105Hening Lin · Cornell University · R01 · FY2014 · CA
NCS-FO: Collaborative Research: Fully-passive and wireless multi-channel neural recording for chronic in-vivo studies in animals
$585,087John L Volakis · Florida International University · · FY2017 · ENG
Testing of a patient-centered e-health implementation model in addiction treatment
$585,043Todd David Molfenter · University Of Wisconsin-Madison · R01 · FY2022 · DA
Continuum of Care for Drug-Involved Offenders
$584,962Peter D. Friedmann · Rhode Island Hospital · U01 · FY2011 · DA